Navigation Links
Many Prostate Cancers Will Not Need Treatment
Date:2/13/2008

Major study finds most older men will die of other causes

WEDNESDAY, Feb. 13 (HealthDay News) -- One of the largest studies of its kind concludes that most older men with early prostate cancer do not shorten their survival odds if they adopt a "wait-and-see" approach to the disease.

In fact, most such patients will die of other causes or they simply won't develop any complications from the cancer, the researchers found.

"Many elderly men with lower risk cancer may do well with conservative management," concluded study author Grace Lu-Yau, a cancer epidemiologist at the Cancer Institute of New Jersey, and an associate professor at UMDNJ-Robert Wood Johnson Medical School and School of Public Health.

"Each patient facing a treatment decision has to ask himself what is the potential survival benefit of various treatments and the potential side effects of various treatments, then compare this potential risk of side effects with the potential risk of cancer complications if the cancer is left untreated -- and ask themselves which treatment option is their personal preference," Lu-Yau said.

She presented the findings to reporters at a special teleconference Tuesday, part of the 2008 Genitourinary Cancers Symposium taking place in San Francisco.

The question of whether to treat or not treat prostate cancer has long absorbed experts.

Although one in six men in the United States will be diagnosed with prostate cancer in their lifetime, many of the malignancies are slow-growing, and there is currently no reliable way to identify which men will benefit from treatment. Better knowledge of the natural history of the disease (i.e., what happens without any treatment) would help guide treatment decisions, Lu-Yau said.

This study is one of the first to look at the natural history of prostate cancer since PSA (prostate-specific antigen) blood testing has become commonplace. PSA tests can
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. GPS for the Prostate: System Keeps Radiation Therapy on Target
2. Whats good for the heart may be good for the prostate
3. Whats Good for the Heart May Be Good for the Prostate
4. Men who are continually active at work may have a decreased risk of prostate cancer
5. More Gene Variations Found That Raise Prostate Cancer Risk
6. U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection
7. Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
8. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
9. Men Can Take Their Time to Decide on Prostate Cancer Treatment, Reports the Harvard Mens Health Watch
10. Online tool supports more dialogue on prostate cancer risk
11. Experimental Vaccine Halts Prostate Cancer in Mice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Many Prostate Cancers Will Not Need Treatment
(Date:5/5/2015)... 2015 AxoGen, Inc. (NASDAQ: AXGN), ... $1.6 billion peripheral nerve repair market, reported record revenue ... 31, 2015 compared to $3.14 million in the year-ago ... our proprietary portfolio of nerve repair products - ... Protector – and our solid sales execution delivered another ...
(Date:5/5/2015)... The 2015 Crystal Ball, hosted by the Hepatitis ... outreach and patient advocacy programs. The gala evening included dancing, ... hundreds of supporters. , The 2015 gala was dedicated to ... virus (HBV) by Dr. Baruch S. Blumberg, who passed away ... for his discovery of the virus in 1976. He and ...
(Date:5/5/2015)... 05, 2015 Baptist Medical Center Jacksonville’s ... Cancer (CoC) of the American College of Surgeons. , ... meet more than 30 Commission on Cancer quality care ... process, and maintain levels of excellence in the delivery ... choose to seek care locally at a CoC-accredited cancer ...
(Date:5/5/2015)... " QuickPick Travel ” was featured on NewsWatch as ... small, medium, and large businesses making an impact in their ... expert, conducted the business review and shared with viewers how ... weeks of vacation for free. , Vacations are a sought-after ... world. And when people are preparing for vacations, they’re used ...
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 ProTexting, ... that enables businesses to deploy Mobile Engagement Campaigns and ... Contact . ProTexting clients can now leverage the power ... by collecting and syncing subscribers’ e-mail addresses into the ... “We have recognized that the growing trend of multi-channel ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3
... The Delhi High Court Wednesday held that the misuse of ... seriously, stressing that their services be availed of only ... and Justice S.N. Agrawal said: "No ambulance of any of ... used by the medical staff for their private use." ...
... E. McGreevy appears to be knocking on a different door. ... for the right reasons. He has been welcomed into ... James E. McGreevy, who was brought up as a Roman ... at St. Bartholomew's Church in New York. He is presently ...
... says she was upset when her pictures appeared in magazine ... all that blew up, I felt terrible. It appeared that ... am thin because that's what I am, and I was ... Nothing else," people.com quotes her as saying to a magazine. ...
... official of the United Arab Emirates (UAE) said the government ... part of the country's prevention programme of genetic disorders. ... the mother or child's health. But the choice to have ... we decide has to be within the religious and social ...
... that the malfunction of a gene causes schizophrenia and ... of the journal Neuron. ,The researchers said their ... developing treatments for schizophrenia and depression, which have been ... ,In their experiments, the researchers sought to ...
... who have migraine headaches are more than twice as likely ... than soldiers who do not have migraines, according to ... who were given a health screening questionnaire within 90 days ... A total of 2,167 of the soldiers, or 60 percent, ...
Cached Medicine News:Health News:Malfunction of Gene Causes Schizophrenia, Depression 2Health News:Migraines may Be a Symptom of Other Problems for Iraq Soldiers 2
(Date:5/5/2015)... 5, 2015  Adeptus Health Inc. (NYSE: ADPT ... pricing of the previously announced offering of 2,100,000 shares ... shares are to be sold by the Company, and ... of Sterling Partners (the "Selling Stockholder"), at a price ... the Company and the Selling Stockholder have granted the ...
(Date:5/5/2015)... May 5, 2015   InspireMD, Inc. (NYSE MKT: ... systems, announced today that it will release its full financial ... Monday, May 11 th before the open, followed by ... financial results and business outlook. Participants should call ... 542-4135 (International) and request the InspireMD call. A live webcast ...
(Date:5/5/2015)... , May 5, 2015 Ardelyx, ... company focused on cardio-renal, gastrointestinal, and metabolic diseases, ... trial evaluating tenapanor in Stage 3 chronic kidney ... albuminuria did not meet the primary endpoint of ... compared to patients receiving placebo. ...
Breaking Medicine Technology:Adeptus Health Inc. Announces Pricing of Common Stock Offering 2Adeptus Health Inc. Announces Pricing of Common Stock Offering 3Adeptus Health Inc. Announces Pricing of Common Stock Offering 4InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6
... CHICAGO, Nov. 18, 2010 Northwestern Memorial ... pilot study that will test whether operable lung cancer ... and better outcomes by hardwiring data systems to reduce ... standards.  The 18-month trial co-sponsored by the Commission on ...
... Nov. 18, 2010  Prism Pharmaceuticals, Inc. announced ... (FDA) has approved the supplemental new drug application ... and only premixed intravenous (IV) bag formulation of ... is indicated for initiation of treatment and prophylaxis ...
Cached Medicine Technology:Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study 2Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study 3Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use NEXTERONE® (amiodarone HCl) Premixed Injection 2Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use NEXTERONE® (amiodarone HCl) Premixed Injection 3
Full plate covers seal all 24 MicroAmp tubes...
An alternative sealing method for samples that are stored in 96-well plates after PCR. The mat is fully autoclavable and can be reused up to 50 times....
Inquire...
Pkg qty: box of 2 bags pack of 25 (Pack = Zippered Bag)...
Medicine Products: